Perez Christian, Daniel Kevin B, Cohen Seth M
Department of Chemistry & Biochemistry, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093 (USA).
ChemMedChem. 2013 Oct;8(10):1662-7. doi: 10.1002/cmdc.201300255. Epub 2013 Aug 8.
Prodrugs are effective tools in overcoming drawbacks typically associated with drug formulation and delivery. Those employing esterase-triggered functional groups are frequently utilized to mask polar carboxylic acids and phenols, increasing drug-like properties such as lipophilicity. Herein we detail a comprehensive assessment for strategies that effectively release hydroxy and phenolic moieties in the presence of an esterase. Matrix metalloproteinases (MMPs) serve as our proof-of-concept target. Three distinct ester-responsive protecting groups are incorporated into MMP proinhibitors containing hydroxy moieties. Analytical evaluation of the proinhibitors demonstrates that the use of a benzyl ether group appended to the esterase trigger leads to considerably faster kinetics of conversion and enhanced aqueous stability when compared with more conventional approaches where the trigger is directly attached to the inhibitor. Biological assays confirm that all protecting groups effectively cleave in the presence of esterase to generate the active inhibitor. The superior reaction-based prodrug strategies presented here should serve as a platform for esterase-responsive prodrug design in the future.
前药是克服通常与药物制剂和递送相关缺点的有效工具。那些采用酯酶触发官能团的前药经常被用来掩盖极性羧酸和酚类,增加诸如亲脂性等类药性质。在此,我们详细评估了在酯酶存在下有效释放羟基和酚基部分的策略。基质金属蛋白酶(MMPs)作为我们的概念验证靶点。三种不同的酯响应保护基团被引入到含有羟基部分的MMP前体抑制剂中。对前体抑制剂的分析评估表明,与触发基团直接连接到抑制剂的更传统方法相比,在酯酶触发基团上附加苄基醚基团会导致转化动力学显著加快,并提高在水中的稳定性。生物学测定证实,所有保护基团在酯酶存在下均能有效裂解以产生活性抑制剂。本文提出的基于反应的卓越前药策略应成为未来酯酶响应前药设计的一个平台。